SBIR/STTR Research Award

BIOMIMETIC COATING FOR CENTRAL VENOUS CATHETERS

Award identifier 11f9bf0ed3c546261d3cec9c046f4edcafcf0592eb07b1616c06ccac74bb75ceAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$134,531

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ELECTROSONICS MEDICAL INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Approximately 80% of patients require an intravenous catheter upon hospitalization, and thrombosis (fibrin sheath formation and mural thrombosis) results in a 25 % failure rate. Blood compatible coatings have been investigated in recent years in order to improve material biocompatibility by reducing thrombogenicity through diminished protein adhesion. One of the more promising types of surface biolization technologies is a surfactant polymer coating that attempts to mimic nature, in particular the properties of endothelium. Hydrophobic groups provide surfactant polymer adhesion to the foreign surface and hydrophilic blood-compatible outer groups form an interface with blood flow reducing fibrinogen and platelet adhesion, and thus consequently, thrombus formation. In Phase I of the project, we will determine stability of the surfactant coating on polyurethane through in vitro shear studies corresponding to shear rates experienced by a catheter. Further, a series of ex vivo experiments will be conducted to determine fibrinogen and platelet adsorption to surfactant coated polyurethane surfaces. It is expected that fibrinogen and platelet adhesion will be reduced by at least 80% compared to control materials. If successful, this will demonstrate the feasibility of surfactant coating for venous catheters. PROPOSED COMMERCIAL APPLICATIONS: Catheter improvements have shown cost savings, with a simple improvement in catheter securement resulting in a 76% reduction in unscheduled nurse visits and a 68% decrease in unscheduled catheter restarts. Such improvement could cut costs by more than $58 per patient per month. In 1998, the worldwide catheter market was $4.41 billion and it is expected to grow to $5.78 billion by the year 2002. In the US the market is expected to grow over $2 billion by 2002. Beyond the immediate application, the surfactant polymer biomimetic coating is designed to be easy to apply (dip coating) and can be tailored to any surface. Even sharing a small percentage of this market through coating services or licensing technology would represent significant income.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.